STOCK TITAN

Madison Avenue group discloses 5% Indivior (INDV) ownership in Schedule 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Indivior Pharmaceuticals, Inc. received a disclosure that a group of investment entities led by Madison Avenue International LP holds a significant minority stake in its ordinary shares. As of February 17, 2026, the group beneficially owned 6,280,502 ordinary shares.

This position represents approximately 5.0% of Indivior’s outstanding ordinary shares, based on 124,853,897 shares outstanding as of October 1, 2025. The reporting investors state that the shares were not acquired for the purpose of changing or influencing control of the company.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Madison Avenue International LP
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
Date:02/17/2026
Madison Avenue Partners, LP
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
Date:02/17/2026
EMAI Management, LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Managing Member
Date:02/17/2026
Madison Avenue GP, LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Manager
Date:02/17/2026
Caraway Jackson Investments LLC
Signature:/s/ Eli Samaha
Name/Title:Eli Samaha, as Member
Date:02/17/2026
Eli Samaha
Signature:/s/ Eli Samaha
Name/Title:ELI SAMAHA
Date:02/17/2026
Indivior Pharmaceuticals Inc

NASDAQ:INDV

INDV Rankings

INDV Latest News

INDV Latest SEC Filings

INDV Stock Data

4.32B
124.77M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SLOUGH, BERKSHIRE